Jeremy Graff is the Chief Scientific Officer at IMV Inc, an early-stage Canadian biotechnology company. Based in Dartmouth, Canada.
Jeremy Graff is the Chief Scientific Officer at IMV Inc, an early-stage Canadian biotechnology company. In this role, he oversees the company's research programs and the development of its cancer vaccine platform. Prior to IMV, Graff served as Chief Development Officer and Senior Vice President, Research at HiberCell and held executive positions at Biothera Pharmaceuticals. He also spent nearly 17 years at Eli Lilly and Lilly Research Labs, where he developed extensive experience in cancer drug discovery and development.
Full founder directory · Investor directory · Company funding database · Fundraising library